Get the Stockscreener App
56.73
0.82%
-0.47
After Hours:
56.93
0.20
+0.35%
Transmedics Group Inc stock is traded at $56.73, with a volume of 2.31M.
It is down -0.82% in the last 24 hours and down -8.06% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$57.20
Open:
$58.22
24h Volume:
2.31M
Relative Volume:
1.06
Market Cap:
$1.90B
Revenue:
$401.09M
Net Income/Loss:
$32.64M
P/E Ratio:
60.35
EPS:
0.94
Net Cash Flow:
$-120.51M
1W Performance:
-9.29%
1M Performance:
-8.06%
6M Performance:
-61.46%
1Y Performance:
-30.97%
1-Day Range:
$55.00
$58.23
1-Week Range:
$55.00
$64.20
52-Week Range:
$55.00
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
56.73 | 1.90B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-22-24 | Downgrade | Needham | Buy → Hold |
| Oct-29-24 | Reiterated | Needham | Buy |
| Oct-29-24 | Reiterated | Oppenheimer | Outperform |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Aug-21-24 | Initiated | Needham | Buy |
| Jun-06-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-24 | Initiated | Stephens | Overweight |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TransMedics Group, Inc.TMDX - PR Newswire
TransMedics Group, Inc. Announcement: If You Have Suffered - GlobeNewswire
TransMedics Group, Inc. Announcement: If You Have Suffered Losses in TransMedics Group, Inc. - The Bakersfield Californian
TransMedics Group, Inc. Announcement: If You Have Suffered Losses in TransMedics Group, Inc. (NASDAQ: TMDX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation - Markets Insider
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman - GlobeNewswire
TMDX Stock Down Despite Responding to Misleading Short-Seller Report - MSN
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX - Markets Insider
TMDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into TransMedics Group, Inc. and Encourages Investors to Contact the Firm - Markets Insider
TransMedics Group (NASDAQ:TMDX) Hits New 12-Month LowWhat's Next? - MarketBeat
Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action InvestigationTMDX - PR Newswire
Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX) - Simply Wall St
Indo-Asian News Service - IANS India Pvt Ltd
When the Price of (TMDX) Talks, People Listen - Stock Traders Daily
Brokerages Set TransMedics Group, Inc. (NASDAQ:TMDX) Target Price at $122.70 - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
TransMedics: Expectations Remain Sky-High Despite Recent Stock Drop - Seeking Alpha
TransMedics Group (NASDAQ:TMDX) Reaches New 1-Year LowHere's Why - MarketBeat
Looking At TransMedics Gr's Recent Unusual Options Activity - Benzinga
TMDX Stock Touches 52-Week Low at $58.27 Amid Market Challenges - Investing.com Australia
TMDX Investigation Reminder: Kessler Topaz Meltzer & Check, LLP - GuruFocus.com
Why TransMedics Fell 15.7% This Week - MSN
TMDX Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. (NASDAQ: TMDX) Investors with Significant Losses to Contact the Firm - Finansavisen
Why TransMedics Group (TMDX) Stock is Moving Today - GuruFocus.com
Transmedics (TMDX) Fell on Investors’ Growing Concerns - Yahoo Finance
TMDX Stock Touches 52-Week Low at $58.27 Amid Market Challenges By Investing.com - Investing.com South Africa
Kirby McInerney LLP Announces Investigation Against TransMedics Group, Inc. (TMDX) on Behalf of Investors - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Why Transmedics Plunged in December - MSN
TransMedics faces fraud, organ trafficking accusations from activist short seller - Mass Device
TransMedics Group (NASDAQ:TMDX) Shares Gap UpShould You Buy? - MarketBeat
TransMedics: Misplaced Fear (NASDAQ:TMDX) - Seeking Alpha
TRANSMEDICS ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
NASDAQ: TMDX Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. (NASDAQ: TMDX) Investors with Significant Losses to Contact the Firm - Business Wire
Transmedics Group Inc (TMDX-Q) QuotePress Release - The Globe and Mail
TransMedics Group (NASDAQ:TMDX) Shares Down 9.5%Here's Why - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Investors to Reach Out - AccessWire
TMDX Investor News: Rosen Law Firm Encourages TransMedics Group, - GuruFocus.com
TMDX Investor News: Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action InvestigationTMDX - Finansavisen
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ TraffickingHagens Berman - PR Newswire
TransMedics Group, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
TransMedics finalizes fleet acquisition for organ transport By Investing.com - Investing.com South Africa
TransMedics finalizes fleet acquisition for organ transport - Investing.com
TMDX Investors Have Opportunity to Join TransMedics Group, Inc. Securities Fraud Investigation with the Schall Law Firm - Business Wire
Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX - Business Wire
TransMedics Group (NASDAQ:TMDX) Stock Price Down 9.5%Should You Sell? - MarketBeat
TRANSMEDICS Is Being Investigated for Potential Securities Law ViolationsContact Kaplan Fox & Kilsheimer LLP - The Globe and Mail
TransMedics Strongly Refutes Short-Seller Claims, Highlights 7,000 Successful Organ Transplants - StockTitan
Scorpion Capital shorts TransMedics, shares down - MSN
TransMedics Stock Is Worth $0 According to This Short-Seller. Here's Why I'm Not Selling. - AOL
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):